GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » YoY EPS Growth

Brawn Biotech (BOM:530207) YoY EPS Growth : 43.78% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Brawn Biotech's YoY EPS Growth for the quarter that ended in Mar. 2024 was 43.78%.

Brawn Biotech's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ₹-1.14.


Brawn Biotech YoY EPS Growth Historical Data

The historical data trend for Brawn Biotech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech YoY EPS Growth Chart

Brawn Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -55.64 -193.10 -198.69 44.54 -69.08

Brawn Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -196.48 -234.88 -19.31 -1,532.26 43.78

Brawn Biotech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Brawn Biotech's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-5.14--3.04)/ | -3.04 |
=-69.08 %

Brawn Biotech's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(-1.139--2.026)/ | -2.026 |
=43.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Brawn Biotech (BOM:530207) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001
Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines